(Q33802224)

29 July 2017

0 references

Aromatase inhibition in relapsing low malignant potential serous tumours of the ovary (English)

1 reference

29 July 2017

Khashayar Esfahani

1

1 reference

29 July 2017

Cristiano Ferrario

series ordinal

2

1 reference

29 July 2017

Philippe Le

series ordinal

3

1 reference

29 July 2017

Lawrence Panasci

series ordinal

4

1 reference

29 July 2017

publication date

12 June 2014

1 reference

29 July 2017

1 reference

29 July 2017

volume

2014

1 reference

Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Diagnosis, treatment, and follow-up of borderline ovarian tumors

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

The management of borderline epithelial tumors of the ovary

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Stage III ovarian tumors of low malignant potential treated with cisplatin combination therapy (a Gynecologic Oncology Group study).

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4069710

Metastasis to sigmoid colon mucosa and submucosa from serous borderline ovarian tumor: response to hormone therapy

4 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FBCR-2014-204287

Remission of a chemotherapy resistant tumor of low malignant potential with tamoxifen

21 January 2018

1 reference

12 December 2020

NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer

1 reference

12 December 2020

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent

1 reference

12 December 2020

Leuprolide acetate in advanced ovarian serous tumor of low malignant potential. A case report

1 reference

12 December 2020

Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants

1 reference

12 December 2020

Estrogen receptor expression is a common feature of ovarian borderline tumors

1 reference

12 December 2020

Identifiers

DOI

10.1136/BCR-2014-204287

1 reference

29 July 2017

1 reference

29 July 2017

1 reference